Hong Kong SAR, China: Market for Human Blood And Animal Blood Prepared For Therapeutic, Pophylactic Or Diagnostic Uses 2022

Market Size for Human Blood And Animal Blood Prepared For Therapeutic, Pophylactic Or Diagnostic Uses in Hong Kong SAR, China

The Hong Kong human and animal blood market fell rapidly to $X in 2021, with a decrease of -X% against the previous year. Over the period under review, consumption, however, posted a notable expansion. Over the period under review, the market hit record highs at $X in 2017; however, from 2018 to 2021, consumption remained at a lower figure.

Production of Human Blood And Animal Blood Prepared For Therapeutic, Pophylactic Or Diagnostic Uses in Hong Kong SAR, China

In value terms, human and animal blood production fell modestly to $X in 2021 estimated in export price. In general, production recorded a relatively flat trend pattern. The pace of growth appeared the most rapid in 2016 with an increase of X% against the previous year. Human and animal blood production peaked at $X in 2017; however, from 2018 to 2021, production failed to regain momentum.

Exports of Human Blood And Animal Blood Prepared For Therapeutic, Pophylactic Or Diagnostic Uses

Exports from Hong Kong SAR, China

In 2021, the amount of human blood and animal blood prepared for therapeutic, pophylactic or diagnostic uses exported from Hong Kong SAR skyrocketed to X tons, with an increase of X% against the year before. Over the period under review, exports enjoyed a remarkable increase. The pace of growth was the most pronounced in 2016 when exports increased by X% against the previous year. The exports peaked at X tons in 2019; however, from 2020 to 2021, the exports remained at a lower figure.

In value terms, human and animal blood exports surged to $X in 2021. In general, exports recorded prominent growth. The exports peaked at $X in 2017; however, from 2018 to 2021, the exports failed to regain momentum.

Exports by Country

Australia (X tons) was the main destination for human and animal blood exports from Hong Kong SAR, with a X% share of total exports. Moreover, human and animal blood exports to Australia exceeded the volume sent to the second major destination, Brazil (X tons), threefold. The third position in this ranking was taken by Mexico (X tons), with a X% share.

From 2012 to 2021, the average annual rate of growth in terms of volume to Australia amounted to +X%. Exports to the other major destinations recorded the following average annual rates of exports growth: Brazil (+X% per year) and Mexico (+X% per year).

In value terms, Australia ($X) remains the key foreign market for human and animal blood exports from Hong Kong SAR, comprising X% of total exports. The second position in the ranking was held by Brazil ($X), with a X% share of total exports. It was followed by Mexico, with an X% share.

From 2012 to 2021, the average annual rate of growth in terms of value to Australia stood at +X%. Exports to the other major destinations recorded the following average annual rates of exports growth: Brazil (-X% per year) and Mexico (+X% per year).

Export Prices by Country

In 2021, the average human and animal blood export price amounted to $X per ton, approximately equating the previous year. In general, the export price showed a perceptible setback. The growth pace was the most rapid in 2015 when the average export price increased by X% against the previous year. As a result, the export price reached the peak level of $X per ton. From 2016 to 2021, the the average export prices remained at a somewhat lower figure.

Average prices varied noticeably for the major external markets. In 2021, the highest price was recorded for prices to Indonesia ($X per ton) and Australia ($X per ton), while the average price for exports to Mexico ($X per ton) and Brazil ($X per ton) were amongst the lowest.

From 2012 to 2021, the most notable rate of growth in terms of prices was recorded for supplies to Japan (-X%), while the prices for the other major destinations experienced a decline.

Imports of Human Blood And Animal Blood Prepared For Therapeutic, Pophylactic Or Diagnostic Uses

Imports into Hong Kong SAR, China

In 2021, imports of human blood and animal blood prepared for therapeutic, pophylactic or diagnostic uses into Hong Kong SAR surged to X tons, picking up by X% against 2020. Overall, imports enjoyed a prominent increase. The growth pace was the most rapid in 2017 with an increase of X% against the previous year. Over the period under review, imports reached the peak figure at X tons in 2019; however, from 2020 to 2021, imports stood at a somewhat lower figure.

In value terms, human and animal blood imports expanded sharply to $X in 2021. In general, imports saw a resilient increase. The pace of growth was the most pronounced in 2017 when imports increased by X%. As a result, imports attained the peak of $X. From 2018 to 2021, the growth of imports remained at a somewhat lower figure.

Imports by Country

Australia (X tons), the United States (X tons) and Austria (X tons) were the main suppliers of human and animal blood imports to Hong Kong SAR, together comprising X% of total imports.

From 2012 to 2021, the most notable rate of growth in terms of purchases, amongst the main suppliers, was attained by Australia (with a CAGR of +X%), while imports for the other leaders experienced more modest paces of growth.

In value terms, the largest human and animal blood suppliers to Hong Kong SAR were the United States ($X), China ($X) and Ireland ($X), with a combined X% share of total imports. Australia, Germany and Austria lagged somewhat behind, together accounting for a further X the main suppliers, Austria, with a CAGR of +X%, recorded the highest rates of growth with regard to the value of imports, over the period under review, while purchases for the other leaders experienced more modest paces of growth.

Import Prices by Country

The average human and animal blood import price stood at $X per ton in 2021, dropping by -X% against the previous year. In general, the import price recorded a noticeable shrinkage. The pace of growth was the most pronounced in 2013 when the average import price increased by X% against the previous year. The import price peaked at $X per ton in 2017; however, from 2018 to 2021, import prices remained at a lower figure.

There were significant differences in the average prices amongst the major supplying countries. In 2021, the country with the highest price was Ireland ($X per ton), while the price for Austria ($X per ton) was amongst the lowest.

From 2012 to 2021, the most notable rate of growth in terms of prices was attained by Austria (+X%), while the prices for the other major suppliers experienced more modest paces of growth.

Source: IndexBox Platform

Frequently Asked Questions (FAQ) :